NexgenRx Inc. (TSXV:NXG)
Canada · Delayed Price · Currency is CAD 0.6000
0.00 (0.00%)
Aug 7, 2026, 1:08 PM EST
NexgenRx Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 18.38 | 17.93 | 16.48 | 13.85 | 12.78 | 11.84 |
Revenue Growth | 9.76% | 8.84% | 18.99% | 8.33% | 7.94% | 7.25% |
Gross Profit Gross Profit Growth | 15.56 | 14.93 | 13.12 | 10.82 | 10.18 | 9.81 |
Operating Income Operating Income Growth | 2.78 | 1.96 | 1.06 | -0.28 | 0.16 | 2.07 |
Net Income Net Income Growth | 1.99 | 1.29 | 0.61 | -0.33 | -0.02 | 4.02 |
Earnings Per Share EPS Growth | 0.02 | 0.01 | 0.01 | -0.01 | - | 0.05 |
EPS Growth | 300.00% | 180.00% | - | - | - | 86.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4.71 | 4.78 | 1.71 | 1.88 | 1.77 | 2.32 |
Total Debt Total Debt Growth | 0.35 | 0.37 | 0.53 | 0.46 | 0.43 | 0.4 |
Net Cash (Debt) Net Cash Growth | 4.37 | 4.41 | 1.17 | 1.41 | 1.33 | 1.92 |
Net Cash Growth | 214.73% | 276.44% | -17.18% | 6.03% | -30.33% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.06 | 0.06 | 0.02 | 0.02 | 0.02 | 0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4.69 | 4.98 | 1.15 | 1.28 | 1.07 | 3.82 |
Capital Expenditures CapEx Growth | -0.26 | -0.3 | -0.09 | -0.08 | -0.39 | -0.13 |
Free Cash Flow Free Cash Flow Growth | 4.42 | 4.68 | 1.06 | 1.2 | 0.68 | 3.7 |
Free Cash Flow Growth | 129.38% | 339.62% | -11.31% | 77.23% | -81.69% | 46.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 84.67% | 83.28% | 79.65% | 78.14% | 79.67% | 82.87% |
Operating Margin | 15.15% | 10.94% | 6.42% | -1.99% | 1.23% | 17.44% |
Pretax Margin | 15.21% | 10.79% | 6.23% | -2.20% | 1.05% | 16.97% |
Profit Margin | 11.74% | 7.19% | 3.73% | -2.40% | -0.18% | 33.93% |
FCF Margin | 24.06% | 26.10% | 6.46% | 8.67% | 5.30% | 31.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.015 | 0.015 | 0.010 | 0.010 | 0.010 |
Dividend Per Share Growth | 50.00% | 50.00% | 0% | 0% | - |
Dividend Yield | 2.50% | 3.75% | 3.58% | 4.54% | 3.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.00 | 28.57 | 56.00 | - | - | 7.41 |
P/FCF Ratio | 9.65 | 6.08 | 18.66 | 12.93 | 28.04 | 7.61 |
PS Ratio | 2.31 | 1.59 | 1.21 | 1.12 | 1.49 | 2.38 |